Home / Inspections / 1203599

FDA Inspection 1203599 — Cooperman Barnabas Medical Center Inc.

Cooperman Barnabas Medical Center Inc. — FEI 2273912

The FDA completed an inspection of Cooperman Barnabas Medical Center Inc. on April 20, 2023 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 20, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)

Facility

Other inspections at this facility

  • 1271693 (NAI Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102095 (NAI Thu Sep 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903748 (VAI Fri Nov 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829353 (VAI Mon Apr 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 746748 (VAI Wed Sep 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources